Eisai's Halaven nabs FDA's 'priority' tag; China fines Fosun for anti-monopoly law breach;

@FiercePharma: Shkreli-shaming spills over onto Valeant as Dems call CEO to account for price hikes. More | Follow @FiercePharma

@EricPFierce: ICYMI: Sun Pharma unit Mutual Pharma recalls 216,766 bottles that may have chemical leaching labels. More | Follow @EricPFierce

@CarlyHFierce: UPDATED: Sorry, Celgene, patent board says. Bass can challenge your IP, and profit, too. Article | Follow @CarlyHFierce

> The FDA has granted Eisai's Halaven its priority review tag as it investigates the drug as a treatment for soft tissue sarcoma. Release

> China has fined a unit of Shanghai Fosun Pharmaceutical Group for acquiring a stake in a Suzhou-based firm without government approval. Report

> Mallinckrodt ($MNK) has completed its acquisition of Therakos. Release

> Novel oral anticoagulants, such as Johnson & Johnson's ($JNJ) Xarelto, need improved safety data if they want to challenge old-guard therapy warfarin, a GlobalData analyst says. Release

Medical Device News

@FierceMedDev: Smith & Nephew launches dissolvable nasal dressing for post-op sinus surgery use. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Medtronic launches smartphone app enabling diabetics to remotely monitor their condition. Article | Follow @VarunSaxena2

@EmilyWFierce: Smiths Medical bucks M&A talk amid revived fortunes. More | Follow @EmilyWFierce

> Precision NanoSystems raises $13.4M Series A for diagnostic, therapeutic nanotech platform. More

> JAMA: Computer-aided detection does not help spot breast cancer. Article

Biotech News

@FierceBiotech: Fierce's coverage of the Martin Shkreli saga. More | Follow @FierceBiotech

@JohnCFierce: Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D. Article | Follow @JohnCFierce

@DamianFierce: I wrote about ~ d i s r u p t i o n ~. Article | Follow @DamianFierce

> With promising RSV data in hand, Novavax wins $89M Gates grant for PhIII. More

> Esperion tanks after inviting Wall Street to parse its regulatory future. Article

> MyoKardia plots an $86M IPO with a novel take on cardio R&D. Story

Drug Delivery News

> MedImmune licenses 3M compound in hopes of developing intratumorally injected cancer drug. Article

> Bayer introduces autoinjector for its multiple sclerosis drug to counter looming generics. Report

> Surefire Medical launches cancer drug delivery catheter. Item

> Molecular 'wrench' gives delivery machinery an edge. Story

> Intarcia buys Phoundry in search of additional diabetes drugs for its subdermal drug pump. Article

Pharma Manufacturing News

> Genovate Biotechnology of Taiwan building $55M insulin plant in China. More

> Jaguar inks deal with Glenmark to produce animal diarrhea drugs. Report

> Manufacturers' association says pharma contract manufacturing in India growing at 20%. Item

> Novartis issues voluntary recall of ADHD drug manufactured in Georgia. Story

> Manufacturing issues result in another blow to Sun Pharma from FDA. Article

Pharma Asia News

> Apotex recalls cevimeline hydrochloride drugs made in India as FDA notes stability issues. Report

> Bill Gates exhorts China healthcare innovators to do good, and well. More

> Indonesia seen spending 18% more on pharmaceuticals in 2015. Item

> AbbVie wins Viekirax nod in Japan as expected with competition seen tight. Story

> India's Sun Pharma research arm sees FDA nod for Elepsia XR yanked by FDA on manufacturing. Article

And Finally... The Patient Advocate Foundation's Co-Pay Relief program is rolling out new financial assistance for HIV and AIDS patients. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.